v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 27, 2024
Oct. 29, 2023
Cash flows from operating activities    
Net income (loss) $ 369,946 $ 7,694
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 85,436 82,252
Share-based compensation expense 224,710 178,897
Non-cash lease expense 24,529 29,399
Change in fair value of equity warrants and investments 875 13,589
Deferred income tax benefit (275,669) 0
Unrealized foreign currency losses, net 1,218 0
Other (141) 3,810
Net change in operating assets and liabilities:    
Accounts receivable (39,208) (34,436)
Inventories (139,454) (36,846)
Prepaid expenses and other current assets (9,892) (27,346)
Other non-current assets 2,803 (1,337)
Trade accounts payable 124,238 48,755
Accrued expenses and other current liabilities 40,440 140,374
Operating lease liabilities (23,088) (19,805)
Other long-term liabilities 2,066 1,664
Net cash provided by operating activities 388,809 386,664
Cash flows from investing activities    
Capital expenditures (92,920) (110,902)
Proceeds from sales and maturities of marketable securities 538,402 750,000
Purchases of marketable securities 0 (876,189)
Cash paid for acquisition of business, net of cash acquired 0 (367)
Net cash provided by (used in) investing activities 445,482 (237,458)
Cash flows from financing activities    
Repurchases of common stock (875,197) 0
Income taxes paid for, net of proceeds from, parent reorganization transaction (53,743) 0
Principal repayments of finance lease obligations (730) (479)
Payments of secondary offering costs (58) 0
Payments for tax withholdings related to vesting of share-based compensation awards (13) (5)
Payments for tax sharing agreement with related parties 0 (10,279)
Payment of debt modification costs 0 (175)
Net cash used in financing activities (929,741) (10,938)
Effect of exchange rate changes on cash and cash equivalents (148) 0
Net (decrease) increase in cash and cash equivalents (95,598) 138,268
Cash and cash equivalents, as of beginning of period 602,232 331,641
Cash and cash equivalents, as of end of period $ 506,634 $ 469,909